CG Oncology, Inc. (NASDAQ: CGON) reported Q3 EPS of ($0.57). Revenue for the quarter came in at $1.67 million versus the consensus estimate of $20 thousand.

For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.